Beyond the visible
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
This thesis aims to improve surgical outcomes in pancreatic ductal adenocarcinoma (PDAC) and epithelial ovarian cancer (EOC) through tumor-targeted molecular imaging. Accurate pre- and intra-operative imaging is critical in these cancers, as conventional modalities (CT, MRI, ultrasound) have limitations, particularly after neoadjuvant therapy. Molecular imaging techniques such as near-infrared fluorescence (NIRF) and positron emission tomography (PET) provide functional and real-time tumor visualization, supporting more precise resection. Part I identifies novel imaging targets. In PDAC, integrin αvβ6 and CEACAM5 emerged as promising targets to distinguish viable tumor from therapy-induced fibrosis after FOLFIRINOX. In EOC, EpCAM showed potential as an alternative to folate receptor-α, reducing false-positive lymph node detection. A transcriptome-based approach further identified B7-H4 as a potential new EOC imaging target, highlighting the need for protein-level validation. Part II evaluates new tracers. Novel FAP-targeted NIRF probes demonstrated specific tumor binding and favorable tumor-to-background ratios in preclinical models. A phase I study of an FR-targeted PET tracer in advanced EOC confirmed safety but showed limited clinical utility. Part III explores dual-target imaging (GRPR and αvβ6) to address tumor heterogeneity and presents a consensus supporting NIRF imaging in pancreatic cancer surgery.
Fields of Study & Subjects
Optical Imaging and Spectroscopy Techniques
Medical Imaging Techniques and Applications
Radiopharmaceutical Chemistry and Applications
Publication details
- Journal / source
- Leiden Repository (Leiden University)
- Publication date
- 26 March 2026
- Language
- EN
- Document type
- Thesis